Longboard Pharmaceuticals Price Target Raised to $36.00/Share From $30.00 by B. Riley Securities

Longboard Pharmaceuticals Price Target Raised to $36.00/Share From $30.00 by B. Riley Securities

Dow JonesJun 12 02:55

Longboard Pharmaceuticals Is Maintained at Buy by B. Riley Securities

Longboard Pharmaceuticals Is Maintained at Buy by B. Riley Securities

Dow JonesJun 12 02:55

H.C. Wainwright Maintains Longboard Pharmaceuticals(LBPH.US) With Buy Rating, Maintains Target Price $60

H.C. Wainwright analyst Patrick Trucchio maintains $Longboard Pharmaceuticals(LBPH.US)$ with a buy rating, and maintains the target price at $60.According to TipRanks data, the analyst has a success r

Futu NewsJun 12 00:31 · Ratings

B. Riley Raises Price Target on Longboard Pharmaceuticals to $36 From $30, Maintains Buy Rating

Longboard Pharmaceuticals (LBPH) has an average investment rating of buy among analysts polled by Capital IQ, with price targets ranging from $32 to $60.

MT NewswiresJun 11 19:45

Citi Maintains Longboard Pharmaceuticals(LBPH.US) With Buy Rating, Maintains Target Price $40

Citi analyst David Hoang maintains $Longboard Pharmaceuticals(LBPH.US)$ with a buy rating, and maintains the target price at $40.According to TipRanks data, the analyst has a success rate of 35.3% and

Futu NewsJun 11 18:31 · Ratings

Express News | Longboard Pharmaceuticals Inc : B. Riley Raises Target Price to $36 From $30

BreakingsJun 11 11:33